Novartis Investigative site

Cranston, Rhode Island 02920

0 studies enrolling now · 2 studies all time

What they study most

COPD, Relapsing Remitting Multiple Sclerosis

Studies at this site

• Evaluation of Patient Retention of Fingolimod vs. Currently Approved Disease Modifying Therapy in Patients With Relapsing Remitting Multiple Sclerosis. — Completed
• Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) — Completed